On the public citation graph
Polypharmacology: The Rise of Multitarget Drugs over Combination Therapies
0 signed · 118 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/9781118098141.ch15openalex-snapshot
Multicomponent Therapeutics
inferredcites →https://doi.org/10.1002/9781118098141.ch20openalex-snapshot
Drug Research Leading to Imatinib and beyond to Nilotinib
inferredcites →https://doi.org/10.1016/j.drudis.2011.08.002openalex-snapshot
The role of fragment-based and computational methods in polypharmacology
inferredcites →https://doi.org/10.1016/j.nurt.2008.10.039openalex-snapshot
Dual- and Triple-Acting Agents for Treating Core and Co-morbid Symptoms of Major Depression: Novel Concepts, New Drugs
inferredcites →https://doi.org/10.1021/jm00120a002openalex-snapshot
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists
inferredcites →https://doi.org/10.1021/jm100293fopenalex-snapshot
Polyamines in Drug Discovery: From the Universal Template Approach to the Multitarget-Directed Ligand Design Strategy
inferredcites →https://doi.org/10.1021/jm7009364openalex-snapshot
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
inferredcites →https://doi.org/10.1021/jm901132vopenalex-snapshot
Selectively Nonselective Kinase Inhibition: Striking the Right Balance
inferredcites →https://doi.org/10.1038/nature08506openalex-snapshot
Predicting new molecular targets for known drugs
inferredcites →https://doi.org/10.1038/nature11691openalex-snapshot
Automated design of ligands to polypharmacological profiles
inferredcites →https://doi.org/10.1038/nrc2787openalex-snapshot
Targeting the cancer kinome through polypharmacology
inferredcites →https://doi.org/10.1038/nrg2918openalex-snapshot
Network medicine: a network-based approach to human disease
inferredcites →https://doi.org/10.1039/9781849734912-00001openalex-snapshot
Simple Drugs Do Not Cure Complex Diseases: The Need for Multi-Targeted Drugs
inferredcites →https://doi.org/10.1039/9781849734912-00155openalex-snapshot
Combination Agents Versus Multi-Targeted Agents – Pros and Cons
inferredcites →https://doi.org/10.1208/s12248-012-9421-yopenalex-snapshot
How Promiscuous Are Pharmaceutically Relevant Compounds? A Data-Driven Assessment
inferredcites →https://doi.org/10.2174/0929867311320130004openalex-snapshot
Polypharmacology in a Single Drug: Multitarget Drugs
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/9783527674381.ch1openalex-snapshot
Polypharmacology in Drug Discovery
inferred← citeshttps://doi.org/10.1002/ange.202006725openalex-snapshot
Hydroxamic Acids Immobilized on Resins (HAIRs): Synthese von Dual‐Target‐HDAC‐Inhibitoren und HDAC‐PROTACs
inferred← citeshttps://doi.org/10.1002/anie.202006725openalex-snapshot
Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual‐Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)
inferred← citeshttps://doi.org/10.1002/cmdc.201500422openalex-snapshot
Nature‐Inspired Multifunctional Ligands: Focusing on Amyloid‐Based Molecular Mechanisms of Alzheimer's Disease
inferred← citeshttps://doi.org/10.1002/ddr.21704openalex-snapshot
Hybrid molecules based on 1,3,5‐triazine as potential therapeutics: A focused review
inferred← citeshttps://doi.org/10.1002/minf.202000012openalex-snapshot
Drug Re‐positioning Studies for Novel HIV‐1 Inhibitors Using Binary QSAR Models and Multi‐target‐driven In Silico Studies
inferred← citeshttps://doi.org/10.1002/minf.202000196openalex-snapshot
Prediction of Promiscuity Cliffs Using Machine Learning
inferred← citeshttps://doi.org/10.1007/7653_2018_6openalex-snapshot
Cheminformatics Approaches to Study Drug Polypharmacology
inferred← citeshttps://doi.org/10.1007/978-1-4939-7404-7_19openalex-snapshot
Computational Modeling of Multi-target-Directed Inhibitors Against Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-031-04998-9_2openalex-snapshot
Strategies of Polypharmacology
inferred← citeshttps://doi.org/10.1007/978-3-031-04998-9_6openalex-snapshot
Polypharmacology in Clinical Applications: Neurological Polypharmacology
inferred← citeshttps://doi.org/10.1007/978-3-031-62604-3_9openalex-snapshot
Network-Pharmacology and Central Nervous System Drug Development
inferred← citeshttps://doi.org/10.1007/978-981-15-8179-3_11openalex-snapshot
Futuristic Approaches Towards Designing of Isozyme-Selective Histone Deacetylase Inhibitors Against Zinc-Dependent Histone Deacetylases
inferred← citeshttps://doi.org/10.1007/s00044-017-2101-9openalex-snapshot
Discovery of a novel multifunctional carbazole–aminoquinoline dimer for Alzheimer's disease: copper selective chelation, anti-amyloid aggregation, and neuroprotection
inferred← citeshttps://doi.org/10.1007/s00520-019-05229-7openalex-snapshot
What is the evidence for mirtazapine in treating cancer-related symptomatology? A systematic review
inferred← citeshttps://doi.org/10.1007/s11030-024-10807-xopenalex-snapshot
Design, synthesis, and biological evaluation of new biaryl derivatives of cycloalkyl diacetamide bearing chalcone moiety as type II c-MET kinase inhibitors
inferred← citeshttps://doi.org/10.1007/s11172-018-2282-5openalex-snapshot
Influence of the γ-carboline and carbazole pharmacophore moieties on anticholinesterase and antiradical activity of multifunctional agents for the treatment of neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/b978-0-08-102083-8.00001-7openalex-snapshot
Multitargeting Heterocycles
inferred← citeshttps://doi.org/10.1016/b978-0-323-89775-4.00010-9openalex-snapshot
Computational approaches in drug designing
inferred← citeshttps://doi.org/10.1016/bs.apcsb.2018.03.005openalex-snapshot
Computational Methods to Discover Compounds for the Treatment of Chagas Disease
inferred← citeshttps://doi.org/10.1016/j.bioorg.2019.103100openalex-snapshot
Triazole substituted metal-free, metallo-phthalocyanines and their water soluble derivatives as potential cholinesterases inhibitors: Design, synthesis and in vitro inhibition study
inferred← citeshttps://doi.org/10.1016/j.bmc.2022.116922openalex-snapshot
The overview of Mitogen-activated extracellular signal-regulated kinase (MEK)-based dual inhibitor in the treatment of cancers
inferred← citeshttps://doi.org/10.1016/j.canlet.2015.02.029openalex-snapshot
Disruption of the unfolded protein response (UPR) by lead compound selectively suppresses cancer cell growth
inferred← citeshttps://doi.org/10.1016/j.cbi.2022.110092openalex-snapshot
Kinetic and structural studies on the inhibition of acetylcholinesterase and butyrylcholinesterase by a series of multitarget-directed galantamine-peptide derivatives
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2022.105410openalex-snapshot
Caffeoyl malic acid is a potential dual inhibitor targeting TNFα/IL-4 evaluated by a combination strategy of network analysis-deep learning-molecular simulation
inferred← citeshttps://doi.org/10.1016/j.ejmech.2019.04.038openalex-snapshot
A multifunctional therapeutic approach: Synthesis, biological evaluation, crystal structure and molecular docking of diversified 1H-pyrazolo[3,4-b]pyridine derivatives against Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.114039openalex-snapshot
Molecular design of dual inhibitors of PI3K and potential molecular target of cancer for its treatment: A review
inferred← citeshttps://doi.org/10.1016/j.ejmech.2022.114232openalex-snapshot
Recent development of BTK-based dual inhibitors in the treatment of cancers
inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.116393openalex-snapshot
Dual-target inhibitors based on ERα: Novel therapeutic approaches for endocrine resistant breast cancer
inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.116569openalex-snapshot
New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands
inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.116810openalex-snapshot
Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.117029openalex-snapshot
Discovery of cloxiquine derivatives as potent HDAC inhibitors for the treatment of melanoma via activating PPARγ
inferred← citeshttps://doi.org/10.1016/j.eq.2015.05.002openalex-snapshot
Avances en el diseño de fármacos asistido por computadora
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2022.12.013openalex-snapshot
Recent development of multi-targeted inhibitors of human topoisomerase II enzyme as potent cancer therapeutics
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2023.127440openalex-snapshot
Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review
inferred← citeshttps://doi.org/10.1016/j.molstruc.2024.138276openalex-snapshot
Assessing indole derivative molecules as dual acetylcholinesterase and butyrylcholinesterase inhibitors through In Vitro inhibition and molecular modelling studies
inferred← citeshttps://doi.org/10.1016/j.phrs.2015.08.018openalex-snapshot
Multiple binding sites in the nicotinic acetylcholine receptors: An opportunity for polypharmacolgy
inferred← citeshttps://doi.org/10.1016/j.phrs.2017.08.004openalex-snapshot
Curcumin in Alzheimer’s disease: Can we think to new strategies and perspectives for this molecule?
inferred← citeshttps://doi.org/10.1016/j.rechem.2026.103159openalex-snapshot
Identification of quinolinyl-containing dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors with moderate potency towards acetylcholinesterase
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c01961openalex-snapshot
Design, Synthesis, and Bioactivity Evaluation of Dual-Target Inhibitors of Tubulin and Src Kinase Guided by Crystal Structure
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c00100openalex-snapshot
Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c01119openalex-snapshot
4-Acyl Pyrrole Capped HDAC Inhibitors: A New Scaffold for Hybrid Inhibitors of BET Proteins and Histone Deacetylases as Antileukemia Drug Leads
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c02225openalex-snapshot
Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00866openalex-snapshot
Discovery of Novel Src Homology-2 Domain-Containing Phosphatase 2 and Histone Deacetylase Dual Inhibitors with Potent Antitumor Efficacy and Enhanced Antitumor Immunity
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c02183openalex-snapshot
Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01119openalex-snapshot
Novel Tacrine–Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b00726openalex-snapshot
Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer-Related Targets
inferred← citeshttps://doi.org/10.1021/acs.jproteome.2c00550openalex-snapshot
Concentration-Dependent Enrichment Identifies Primary Protein Targets of Multitarget Bioactive Molecules
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.0c00901openalex-snapshot
Systematic Data Analysis and Diagnostic Machine Learning Reveal Differences between Compounds with Single- and Multitarget Activity
inferred← citeshttps://doi.org/10.1021/acsomega.7b01849openalex-snapshot
X-ray-Structure-Based Identification of Compounds with Activity against Targets from Different Families and Generation of Templates for Multitarget Ligand Design
inferred← citeshttps://doi.org/10.1021/acsomega.8b03481openalex-snapshot
Promiscuous Ligands from Experimentally Determined Structures, Binding Conformations, and Protein Family-Dependent Interaction Hotspots
inferred← citeshttps://doi.org/10.1021/acsomega.8b03639openalex-snapshot
Recent Progress in Structure-Based Evaluation of Compound Promiscuity
inferred← citeshttps://doi.org/10.1021/acsomega.9b00492openalex-snapshot
Prediction of Different Classes of Promiscuous and Nonpromiscuous Compounds Using Machine Learning and Nearest Neighbor Analysis
inferred← citeshttps://doi.org/10.1021/acsptsci.4c00709openalex-snapshot
Contilisant-Belinostat Hybrids: Polyfunctionalized Indole Derivatives as Multineurotarget Drugs for the Potential Treatment of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1038/s41597-024-03734-xopenalex-snapshot
KORE-Map 1.0: Korean medicine Omics Resource Extension Map on transcriptome data of tonifying herbal medicine
inferred← citeshttps://doi.org/10.1038/s41598-022-09019-wopenalex-snapshot
Nigratine as dual inhibitor of necroptosis and ferroptosis regulated cell death
inferred← citeshttps://doi.org/10.1038/srep33172openalex-snapshot
In Vivo Characterization of ARN14140, a Memantine/Galantamine-Based Multi-Target Compound for Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1038/srep45627openalex-snapshot
Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment
inferred← citeshttps://doi.org/10.1039/d1md00056jopenalex-snapshot
Introducing the metacore concept for multi-target ligand design
inferred← citeshttps://doi.org/10.1055/s-0040-1713873openalex-snapshot
Dual Inhibitors Targeting DNA and Histone Deacetylases
inferred← citeshttps://doi.org/10.1080/14756366.2016.1235042openalex-snapshot
Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors
inferred← citeshttps://doi.org/10.1080/14756366.2016.1238366openalex-snapshot
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase
inferred← citeshttps://doi.org/10.1080/14756366.2023.2242714openalex-snapshot
Design and synthesis of new spirooxindole candidates and their selenium nanoparticles as potential dual Topo I/II inhibitors, DNA intercalators, and apoptotic inducers
inferred← citeshttps://doi.org/10.1080/17460441.2016.1227317openalex-snapshot
The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors
inferred← citeshttps://doi.org/10.1080/17460441.2024.2373165openalex-snapshot
An update on the novel methods for the discovery of antiseizure and antiepileptogenic medications: where are we in 2024?
inferred← citeshttps://doi.org/10.1093/bib/bbw018openalex-snapshot
Weak-binding molecules are not drugs?—toward a systematic strategy for finding effective weak-binding drugs
inferred← citeshttps://doi.org/10.1097/cm9.0000000000002195openalex-snapshot
Treating non-small cell lung cancer by targeting the PI3K signaling pathway
inferred← citeshttps://doi.org/10.1101/2020.12.15.422885openalex-snapshot
Nigratine as first-in-class dual inhibitor of necroptosis and ferroptosis regulated cell death
inferred← citeshttps://doi.org/10.1371/journal.pone.0165737openalex-snapshot
The Human Kinome Targeted by FDA Approved Multi-Target Drugs and Combination Products: A Comparative Study from the Drug-Target Interaction Network Perspective
inferred← citeshttps://doi.org/10.1515/pac-2017-0308openalex-snapshot
Focused design of polypharmacophoric neuroprotective compounds: Conjugates of γ-carbolines with carbazole derivatives and tetrahydrocarbazole
inferred← citeshttps://doi.org/10.2174/0929867330666221209102650openalex-snapshot
Mutual Prodrugs - Codrugs
inferred← citeshttps://doi.org/10.2174/1381612822666160224142812openalex-snapshot
Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective
inferred← citeshttps://doi.org/10.2174/1568026621666211111153626openalex-snapshot
The Hybrid Compounds as Multi-target Ligands for the Treatment of Alzheimer's Disease: Considerations on Donepezil
inferred← citeshttps://doi.org/10.2174/1570180819666220314144219openalex-snapshot
Progress and Development of Carbazole Scaffold Based as Potential Anti- Alzheimer Agents Using MTDL Approach
inferred← citeshttps://doi.org/10.22146/ijc.53411openalex-snapshot
Antimicrobial and Anti-Oxidative Activities of 12-Arylbenzoacridines
inferred← citeshttps://doi.org/10.29356/jmcs.v60i3.100openalex-snapshot
One Drug for Multiple Targets: A Computational Perspective
inferred← citeshttps://doi.org/10.3389/fchem.2020.00176openalex-snapshot
A Definition of “Multitargeticity”: Identifying Potential Multitarget and Selective Ligands Through a Vector Analysis
inferred← citeshttps://doi.org/10.3390/biom10071016openalex-snapshot
Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection
inferred← citeshttps://doi.org/10.3390/ijms21113782openalex-snapshot
X-ray Structure-Based Chemoinformatic Analysis Identifies Promiscuous Ligands Binding to Proteins from Different Classes with Varying Shapes
inferred← citeshttps://doi.org/10.3390/ijms26146996openalex-snapshot
AI-Driven Polypharmacology in Small-Molecule Drug Discovery
inferred← citeshttps://doi.org/10.3390/molecules21040400openalex-snapshot
Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease Therapy
inferred← citeshttps://doi.org/10.3390/molecules24224185openalex-snapshot
Identifying Promiscuous Compounds with Activity against Different Target Classes
inferred← citeshttps://doi.org/10.3390/molecules25030645openalex-snapshot
Discovery of Novel Inhibitors Targeting Multi-UDP-hexose Pyrophosphorylases as Anticancer Agents
inferred← citeshttps://doi.org/10.3390/molecules25122872openalex-snapshot
Structure-Based Discovery of Dual-Target Hits for Acetylcholinesterase and the α7 Nicotinic Acetylcholine Receptors: In Silico Studies and In Vitro Confirmation
inferred← citeshttps://doi.org/10.3390/molecules25174005openalex-snapshot
Memantine Derivatives as Multitarget Agents in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.3390/molecules28031061openalex-snapshot
Solid-Phase Parallel Synthesis of Dual Histone Deacetylase-Cyclooxygenase Inhibitors
inferred← citeshttps://doi.org/10.3390/ph15030333openalex-snapshot
Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin–HDAC Inhibitor Hybrids as Multitarget Drugs
inferred← citeshttps://doi.org/10.4155/fmc-2015-0006openalex-snapshot
Polypharmacology: In Silico Methods of Ligand Design and Development
inferred← citeshttps://doi.org/10.4155/fmc-2016-0003openalex-snapshot
Multitarget Strategies in Alzheimer’S Disease: Benefits and Challenges on the Road to Therapeutics
inferred← citeshttps://doi.org/10.4155/fmc-2017-0039openalex-snapshot
Multitarget Drug Design Strategy in Alzheimer'S Disease: Focus on Cholinergic Transmission and Amyloid-β Aggregation
inferred← citeshttps://doi.org/10.4155/fmc-2017-0050openalex-snapshot
Multiple Target-Centric Strategy to Tame Inflammation
inferred← citeshttps://doi.org/10.4155/fmc-2017-0094openalex-snapshot
Advances Toward Multifunctional Cholinesterase and β-Amyloid Aggregation Inhibitors
inferred← citeshttps://doi.org/10.4155/fmc-2018-0423openalex-snapshot
Lights and Shadows of Electrophile Signaling: Focus on the Nrf2-Keap1 Pathway
inferred← citeshttps://doi.org/10.4155/fmc.14.112openalex-snapshot
Multitarget Inhibitors Derived from Crosstalk Mechanism Involving VEGFR2
inferred← citeshttps://doi.org/10.4155/fmc.15.167openalex-snapshot
One Size Does Not Fit All: Challenging Some Dogmas and Taboos in Drug Discovery
inferred← citeshttps://doi.org/10.52711/0974-360x.2021.00774openalex-snapshot
Combination Vs. Multi-target drugs: The Clash of the titans in the arena of drug discovery; An overview and in silico evaluation
inferred← citeshttps://doi.org/10.5530/ijper.54.2.27openalex-snapshot
Small Molecules Polypharmacology for the Treatment of Breast Cancer: A Roadmap for the Future Chemotherapy
inferred← citeshttps://doi.org/10.70675/6e135d5fzb953z4ffcz9041z2684784040adopenalex-snapshot
The organoid revolution to assess mycobacterial pulmonary infections
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.